Small Intestinal Neuroendocrine Tumor Active Not Recruiting Phase 2 Trials for Surufatinib (DB15106)

Also known as: Small intestine neuroendocrine tumour / Small intestine neuroendocrine tumor / Small Intestinal NET / Neuroendocrine neoplasm of small intestine (disorder)

IndicationStatusPhase
DBCOND0106746 (Small Intestinal Neuroendocrine Tumor)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04579679Open-Label Surufatinib in European Patients With NETTreatment